Genetic renal disease

Current Opinion in Pediatrics

Volumn 10, Issue 2, 1998, Pages 174-183

  Saborio, Pablo ^a   Scheinman, Jon ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 3; GLYCOGEN; OXALIC ACID; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE;

ALAGILLE SYNDROME; ALPORT SYNDROME; CHILD; COCKAYNE SYNDROME; FABRY DISEASE; GENETIC DISORDER; GLOMERULOPATHY; GLOMERULOSCLEROSIS; GLOMERULUS BASEMENT MEMBRANE; GLYCOGEN STORAGE DISEASE TYPE 1; HUMAN; INBORN ERROR OF METABOLISM; KIDNEY DISEASE; KIDNEY INJURY; KIDNEY INTERSTITIUM; KIDNEY POLYCYSTIC DISEASE; LIPOPROTEIN DEFICIENCY; MARFAN SYNDROME; NAIL PATELLA SYNDROME; NEPHRONOPHTHISIS; NEUROFIBROMATOSIS; OBSTRUCTION; OXALOSIS 1; PRIORITY JOURNAL; REVIEW;

EID: 0031832594     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-199804000-00011     Document Type: Review

References (73)

1. Kissane JM, Bernstein J: Hereditary nephritis. In Pediatric Kidney Disease. Edited by Edelman C. Boston: Little Brown; 1992:1159-1170.
2. Foreman JW, Chan JCM: Chronic renal failure in infants and children. J Pediatr 1988, 113:793-800.
3. Grunfeld JP: Hereditary renal diseases. Saudi J Kidney Dis Transplant 1997, 8:227-234. The current findings in genetics, epidemiologic data, and relevant concepts in clinical diagnosis and management of some inherited renal diseases are summarized.
4. Kasinath BS, Kanwar YS: Glomerular basement membrane: biology and physiology. In Mollecullar and Cellular Aspects of Basement membranes, edn 1. Edited by Rohrbach DH, Timpl R. San Diego: Academic Press Inc; 1993:89-106.
5. Morita M, White RHR, Raafat F, Barnes JM, Standring DM: Glomerular basement membrane thickness in children. Pediatr Nephrol 1989, 2:190-195.
6. Langeveld JPM, Veerkamp JH, Duyf CHP, Monnens L: Chemical characterization of glomerular and tubular basement membranes of men of different ages. Kidney Int 1981, 20:104-114.
7. Smeets HJM, Knoers VVAM, van de Heuvel LPWJ, Lemmink HH, Schroder CH, Monnens LAH: Hereditary disorders of the glomerular basement membrane. Pediatr Nephrol 1996, 10:779-788. Increased knowledge of the biochemical composition of the glomerular basement membrane and the introduction of molecular genetics has contributed in the understanding of hereditary disorders of the glomerular basement membrane. In this review, three disorders are highlighted: Alport's syndrome, nail-patella syndrome, and Drash syndrome.
8. 2: Nephrosis despite molecular compensation by laminin B1. Nature Genet 1995, 10:400-405.
9. Kasinath BS, Singh AK, Kanwar YS, Lewis EJ: Effect of puromycin aminonucleoside on HSPG core protein content of glomerular epithelial cells. Am J Physiol 1988, 255: F590-F596.
10. Gubler MC, Deschenes G, Antignac C, Broyer M: Alport syndrome: From the symptoms to the gene. In Pediatric and Adolescent Medicine. Edited by Drukker A, Gruskin AB. Basel: Karger AG; 1994:52-62.
11. Gregory MC, Atkin CL: Alport's syndrome, Fabry's disease and nail-patella syndrome. In Diseases of the Kidney, edn 6. Edited by Schrier RW, Gottschalk CW. Boston: Little, Brown & Co.; 1997:561-590.
12. Gubler MC, Antignac C, Knebelmann B: Inherited glomerular disease. In Pediatric Nephrology, edn 3. Edited by Holliday M, Barratt TM, Avner ED. Baltimore: Williams & Wilkins; 1994:515-536. Comprehensive review of the literature about the inherited diseases related to primary defects in the glomerular basement membrane, requiring only recent updates.
13. Gretz N, Broyer M, Brunner FP: Alport syndrome as a cause of renal failure in Europe. Pediatr Nephrol 1987, 1:411-415.
14. Gubler MC, Levy M, Broyer M: Alport's syndrome: A report of 58 cases and a review of the literature. Am J Med 1981, 70:493-505.
15. Perrin D, Junger P, Grunfeld JG, Delons S, Noel LH, Zenatti C: Perimacular changes in Alport syndrome. Clin Nephrol 1980, 13:163-167.
16. Sabates R, Krachmer JH, Weingeist TA: Ocular findings in Alport syndrome. Ophtalmologica 1983, 186:204.
17. Garcia-Torres R, Orozco L: Alport leyomiomatosis syndrome: An update. Am J Kidney Dis 1993, 22:641
18. Kashtan CE, Michael AF: Alport syndrome: From the bedside to genome to bedside. Am J Kidney Dis 1993, 22:627-640.
19. Oison DL, Anand SK, Landing BH, Heuser E, Grushkin CM, Lieberman E: Diagnosis of hereditary nephritis by failure of glomeruli to bind antiglomerular basement membrane antibodies. J Pediatr 1980, 96: 697-699.
20. Turco AE, Bresin E, Rosetti S, Peterlin B, Morandi R, Pignatti PF: Rapid DNA-based prenatal diagnosis by genetic linkage in three families with Alport's syndrome. Am J Kidney Dis 1997, 30:174-179.
21. Dische FE, Anderson VER, Keane SJ, Taube D, Bewick M, Parsons V: Incidence of thin membrane nephropathy: Morphometric investigation of a population sample. J Clin Pathol 1990, 43:457-460.
22. Lemmink HH, Nillesen WN, Mochizuki T, Schroder CH, Brunner HG, van Oost BA, Monnens LAH, Smeets HJM: Benign familial hematuria due to mutation of the type IV collagen a4 gene. J Clin Invest 1996, 98:1114-1118. The authors present the linkage of benign familial hematuria with the COL4A3 and COL4A4 genes at 2q35-37. A glycine to glutamic acid substitution was identified in the collagenous region of the COL4A4 gene. They conclude that type IV collagen defects cause both benign hematuria and Alport's syndrome. They suggest that patients with benign familial hematuria can be carriers of autosomal recessive Alport's syndrome.
23. Yamazaki H, Nakagawa Y, Saito A, Nishi S, Sakatsume M, Takeda T, Maruyama Y, Ogino S, Maruyama S, Mochizuki T, Reeders S, Arakawa M: No linkage to the COL4A3 gene locus in Japanese thin basement membrane disease families. Nephrol 1995, 1:315-321.
24. Bobrie G, Grunfeld JP: Nail-patella syndrome and other rare inherited disorders with glomerular involvement. In Oxford Textbook of Clinical Nephrology. Edited by Cameron S, Davison AM, Grunfeld JP, Kerr D, Ritz E. New York: Oxford University Press; 1992:2214-2217.
25. Looij B: Genetic counseling in hereditary osteo-onychodysplasia (HOOD, nail-patella syndrome) with nephropathy. J Med Genet 1988, 25:682.
26. Taguchi T: Nephropathy of nail-patella syndrome. Ultrastruc Pathol 1988, 12:175.
27. Chan PC, Chan KW, Cheng IK, Chan MK : Living-related renal transplantation in a patient with nail-patella syndrome. Nephron 1988, 50:164-166.
28. Gubler MC, Dommergues JP, Foulard M, Bensman A, Leroy JP, Broyer M, Habib R: Collagen type III glomerulopathy: A new type of hereditary nephropathy. Pediatr Nephrol 1993, 7:354-360.
29. Ikeda K, Yokoyama H, Tomosugi M, Kida H, Ooshima A, Kobayashi K: Primary glomerular fibrosis: A new nephropathy caused by diffuse intra-glomerular increase in atypical type III collagen fibers. Clin Nephrol 1990, 33:155-159.
30. Strom EH, Banfi G, Krapf R, Abt AB, Mazzucco G, Monga G, Gloor F, Neuweiler J, Riess R, Stosiek P, Hebert LA, Sedmak DD, Gudat F, Mihatsch J: Glomerulopathy associated with predominant fibronectin deposits: A newly recognized hereditary disease. Kidney Int 1995, 48:163-170.
31. Hildebrant F, Jungers P, Grunfeld JP: Medullary cystic and Medullary sponge renal disorders. In Diseases of the Kidney, edn 6. Edited by Schrier RW, Gottschalk CW. Boston: Little, Brown & Co.; 1997:500-520.
32. Konrad M, Saunier S, Heidet L, Silbermann F, Benessy F, Calado J, Le Paslier D, Broyer M, Gubler MC, Antignac C: Large homozygous deletions of the 2q13 region are a major cause of juvenile nephronophthisis. Hum Mol Genet 1996, 5:367-371.
33. Watkins SL, Avner ED: Renal dysplasia and cystic disease. In Pediatric Nephrology, edn 3. Edited by Holliday M, Barratt M, Avner E. Baltimore: Williams & Wilkins; 1994:467-490.
34. Saunier S: Linkage analysis in familial interstitial nephritis. J Am Soc Nephrol 1994, 5:652.
35. 99mtechnetium-mercaptoacetyltriglycine renogram in nephronophthisis. Pediatr-Nephrol 1996, 10:167-170.
36. Gretz N, Scharer K, Waldher R, Strauch M: Rate of deterioration of renal function in juvenile nephronophthisis. Pediatr Nephrol 1989, 3:56.
37. Barnes EG, Opitz JM: Renal abnormalities in malformation syndromes. In Pediatric Kidney Disease, edn 2. Edited by Edelmann CM. Boston: Little, Brown, and Company. 1992:1067-1119.
38. Morgan SH: Anderson-Fabry disease and other inherited metabolic storage disorders with significant renal involvement. In Oxford Textbook of Clinical Nephrology. Edited by Cameron S, Davison AM, Grunfeld JP, Ken D, Ritz E. New York: Oxford University Press; 1992:2205-2214.
39. Desnick RJ, Astrin KH, Bishop DF: Fabry disease: Molecular genetics of the inherited nephropathy. Adv Nephrol 1989, 18:113-128.
40. Morgan SH, Rudge P, Smith SJ, Bronstein AM, Kendall BE, Holly E, Young EP, Crawfurd MD, Bannister R: The neurological complications of Anderson-Fabry disease (alpha-galactosidase A deficiency): Investigation of symptomatic and presymptomatic patients. Q J Med 1990, 75:491-507.
41. Azoulay M: The structural gene for lecithin: Cholesterol acyltransferase maps to human chromosome 16q22. Ann Hum Genet 1987, 51:129-136.
42. Kajihara S, Matsuhashi S, Yamamoto K, Kido K, Tsuji K, Tanae A, Fujiyama S, Itoh T, Tanigawa K, Uchida M: Exon redefinition by a point mutation within exon 5 of the glucose-6-phosphatase gene is the major cause of glycogen storage disease type 1a in Japan. Am J Hum Genet 1995, 57:549-555.
43. Chen YT, Van Hove JLK: Renal involvement in type I glycogen storage disease. Adv Nephrol 1995, 24:357-365.
44. Scheinman J: Glycogen storage disease. In Pediatric Nephrology, edn 4. Edited by Holliday M, Barratt TM, Avner ED. Baltimore: Williams 4 Wilkins, 1998, in press. Starting from the biochemical basis of the disease, the consequences of altered pathways and the renal adaptative mechanisms to the metabolic injury, the author emphasizes that knowledge of the clinical features is required to reach safe and optimal management in GSD-I patients.
45. Chen YT, Coleman RA, Scheinman JI, Kolbeck PC, Sidbury JB: Renal disease In type I glycogen storage disease. N Engl J Med 1988, 318:7-11.
46. Poe R, Snover DC: Adenomas in glycogen storage disease type I two cases with unusual histologic features. Arch Pathol Lab Med 1988, 12:477-483.
47. Kikuchi M, Hagunoya K, Miyabayashi S: Secondary amyloidosis in glycogen storage disease type 1b. Eur J Pediatr 1990, 149:344-345.
48. Cochat P, Deloraine A, Olive F, Rolland MO, Gillet Y, Divry P, Scharer K: Primary hyperoxaluria type 1: The therapeutic dilemma. Adv Nephrol 1995, 24:227-242.
49. Latta K, Brodehl J: Primary hyperoxalurla type I. Eur J Pediatr 1990, 149:518-522.
50. Hoppe B, Danpure CJ, Rumsby G, Fryer P, Jennings PR, Blau N, Schubiger G, Neuhaus T, Leumann E: A vertical (pseudodominant) pattern of inheritance in the autosomal recessive disease primary hyperoxaluria type 1: Lack of relationship between genotype, enzymic phenotype and disease severity. Am J Kidney Dis 1997, 29:36-44.
51. Scheinman J: Primary hyperoxaluria. Miner Electrolyte Metab 1994, 20:340-351.
52. Scheinman J: Primary hyperoxaluria: Therapeutic strategies for the 90's. Kidney Int 1991, 40:389-399.
53. Marangella M, Petraulo M, Bianco O, Vitale C, Finocchiaro P, Linari F: Glycolate determination defects of type 1 primary hyperoxaluria in dialysis patients. Kidney Int 1991, 39:149-154.
54. Danpure CJ, Jennings PR, Fryer P, Purdue PE, Allsop J: Primary hyperoxaluria type 1: Genotypic and phenotypic heterogeneity. J Inherit Metab Dis 1994, 17:487-499.
55. Scheinman JI, Naharian JS, Mauer SM: Successful strategies for renal transplantation in primary oxalosis. Kidney Int 1984, 25:804-811.
56. Broyer M, Brunner FP, Brynger H, Dykes SR, Ehrich JHH, Fassbinder W, Geerlings W, Rizzoni G, Selwood NH, Tufveson G, Wing AJ: Kidney transplantation in primary oxalosis: Data from the EDTA registry. Nephrol Dial Transplant 1990, 5:332-336.
57. Scheinman JI, Alexander M, Campbell ED, Chan JC, Latla K, Cochat P: Transplantation for primary hyperoxaluria in the USA. Nephrol Dial Transplant 1995, 10:S42-S46. A survey of US data (NAPRTCS and USRDS) was made for transplantation in PH. The results showed that transplant is better than no transplant; cadaver donation results are poor; living related kidney donation can succeed; and kidney-liver transplant is still problematic in the United States. Until a more cooperative effort can be achieved, isolated kidney living related donor transplant is preferable and does not preclude kidney-liver transplant later.
58. Scheinman JI: Transplantation in primary hyperoxaluria. In Pediatric Transplantation, edn 8. Edited by Fine R, Tejani A. New York: Williams & Wilkins; 1994:349-377.
59. Katz A, Kim Y, Scheinman J, Najarian JS, Mauer SM: Long term outcome of kidney transplantation in children with oxalosis. Transplant Proc 1989, 21:2033-2035.
60. Scheinman JI: Primary hyperoxaluria type I: Liver transplantation before end-stage renal disease? Pediatr Nephrol 1993, 7:326-329.
61. Jamieson NV: The European Primary Hyperoxaluria Type I Transplant Registry report on the results of combined liver/kidney transplantation for primary hyperoxaluria 1984-1994. Nephrol Dial Trans 1995, 10:S33-S37.
62. Rotig A, Lehnen A, Rustin P, Chretien D, Bourgeron T, Niaudet P, Munnich A: Kidney involvement in mitochondrial disorders. Adv Nephrol 1995, 24: 367-2378.
63. Strauss J, Freundlich M, Zilleruelo G: Sickle cell hemoglobinopathy. In Pediatric Kidney Disease, edn. Edited by Edelman C. Boston: Little, Brown; 1992:1507-1524
64. van Eps LWS, de Jong PE: Sickle cell disease.ln Diseases of the Kidney, edn 6. Edited by Schrier RW, Gottschalk CW. 1997:561-590.
65. van Eps LWS: Sickle cell disease and the kidney. In Oxford Textbook of Clinical Nephrology. Edited by Cameron S, Davison AM, Grunfeld JP, Kerr D, Ritz E. New York: Oxford University Press; 1992:700-720.
66. Scheinman JI: Sickle cell nephropathy. In Pediatric Nephrology, edn 4. Edited by Holliday M, Barratt TM, Avner ED. Baltimore: Williams & Wilkins; 1998, in press. A comprehensive review about the renal syndromes present in sickle cell nephropathy. The clinical features, pathogenesis, and current concepts in diagnosis and treatment of the patients are shown.
67. Powars DR, Elliot-Mills DD, Chan L, Niland J, Hiti AL, Opas LM, Johnson C: Chronic renal failure in sickle cell disease: Risk factors, clinical course and mortality. Ann Med Int 1992, 115:614-620.
68. Falk RJ, Scheinman JI, Phillips G, Orringer E, Johnson A, Jennette JC: Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin converting enzyme. N Engl J Med 1992, 326:910-915.
69. Habib R, Dommergues JP, Gubler MC: Glomerular mesangiolipidosis in Alagille syndrome. Pediatr Nephrol 1987, 1:455-464.
70. Nance MA, Berry SA: Cockayne syndrome: Review of 140 cases. Am J Med Genet 1992, 42:68-64.
71. Sato H, Saito T, Kurosawa W, Ootaka T, Furuyama T, Yoshinaga K: Renal lesions in Cockayne's syndrome. Clin Nephrol 1988, 29:206-209.
72. Francke U, Futhmayr H: Genes and gene products involved in Marfan syndrome. Semin Thorac Cardiovasc Surg 1993, 5:3-10.
73. Baum MA, Harris HW, Burrows PE, Schofield DE, Somers MJG: Renovascular hypertension in Marfan syndrome. Pediatr Nephrol 1997, 11:499-501.